Medical marijuana in HIV-positive patients: What do we know?

Journal of the International Association of Physicians in AIDS Care

Volumn 8, Issue 6, 2009, Pages 342-346

  Cinti, Sandro ^a  

^a UNIVERSITY OF MICHIGAN HOSPITALS   (United States)

Author keywords

medical marijuana; neuropathy; wasting syndrome

Indexed keywords

CANNABIS;

CANNABIS SMOKING; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; DRUG LEGISLATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MENTAL DISEASE; PAIN; PHYTOTHERAPY; REVIEW; UNITED STATES; WASTING SYNDROME;

CALIFORNIA; CANNABIS; HIV INFECTIONS; HIV WASTING SYNDROME; HUMANS; LEGISLATION, DRUG; MARIJUANA SMOKING; MENTAL DISORDERS; MICHIGAN; PAIN; PHYTOTHERAPY;

EID: 77951218977     PISSN: 15451097     EISSN: 15570886     Source Type: Journal    
DOI: 10.1177/1545109709351167     Document Type: Article

References (41)

1. Michigan Medical Marijuana Act (MMMA). http://www.michigan.gov/mdch/0, 1607,7-132-27417-51869-52138-,00.html. Accessed June 22, 2009.
2. Cohen PJ Medical marijuana: the conflict between scientific evidence and political ideology. Part one of two. J Pain Palliat Care Pharmacother. 2009 ; 23 (1). 4-25.
3. American College of Physicians. Supporting Research Into the Therapeutic Role of Marijuana. Philadelphia: American College of Physicians ; 2008: Position Paper. (Available from American College of Physicians, 190 N. Independence Mall West, Philadelphia, PA 19106.).
4. Medical Student Section of the American Medical Association (AMA), 2008 AMA House of Delegates. http://www.ama-assn.org/ama1/pub/upload/mm/15/mss- refcom-a-08.pdf. Accessed June 22, 2009.
5. Abel EL Marijuana: The First Twelve Thousand Years. New York: Plenum Press ; 1980.
6. US Food and Drug Administration (FDA). Inter-Agency Advisory Regarding Claims That Smoked Marijuana is a Medicine; 2006. http://www.fda.gov/bbs/topics/ NEWS/2006/NEW01362.html. Accessed June 22, 2009.
7. Joy JE, Watson SJ, Benson JA Jr, eds, for the Institute of Medicine. Marijuana and Medicine: Assessing the Science Base. Washington, DC: National Academy Press; 1999.
8. Engels FK, de Jong FA, Mathijssen RH, Erkens JA, Herings RM, Verweij J. Medicinal cannabis in oncology. Eur J Cancer. 2007 ; 43 (18). 2638-2644. (Pubitemid 350151843)
9. Gorter RW Cancer cachexia and cannabinoids. Forsch Komplementarmed. 1999 ; 6 (suppl 3). 21-22.
10. Tramer MR, Carroll D., Campbell FA, et al. Cannabinoids for control of chemotherapy induced nausea and vomiting: quantitative systematic review. BMJ. 2001 ; 323 (7303). 16-21. (Pubitemid 32681999)
11. Rice AS Cannabinoids and pain. Curr Opin Investig Drugs. 2001 ; 2 (3). 399-414. (Pubitemid 32279786)
12. Tomida I., Azuara-Blanco A., House H., Flint M., Pertwee RG, Robson PJ Effect of sublingual application of cannabinoids on intraocular pressure: a pilot study. J Glaucoma. 2006 ; 15 (5). 349-353. (Pubitemid 44434985)
13. Mortati K., Dworetzky B., Devinsky O. Marijuana: an effective antiepileptic treatment in partial epilepsy? A case report and review of the literature. Rev Neurol Dis. 2007 ; 4 (2). 103-106. (Pubitemid 47016207)
14. Walsh D., Nelson KA, Mahmoud FA Established and potential therapeutic applications of cannabinoids in oncology. Support Care Cancer. 2003 ; 11 (3). 137-143. (Pubitemid 36733806)
15. Bhargava HN Potential therapeutic applications of naturally occurring and synthetic cannabinoids. Gen Pharmacol. 1978 ; 9 (4). 195-213. (Pubitemid 8397748)
16. Gilson I., Busalacchi M. Marijuana for intractable hiccups. Lancet. 1998 ; 351 (9098). 267. (Pubitemid 28043959)
17. Holdcroft A., Maze M., Dore C., Tebbs S., Thompson S. A multicenter dose escalation study of the analgesic and adverse effects of an oral cannabis extract (Cannador) for postoperative pain management. Anesthesiology. 2006 ; 104 (5). 1040-1046.
18. Strasser F., Luftner D., Possinger K., et al., and the Cannabis-In-Cachexia-Study-Group. Comparison of orally administered cannabis extract and delta-9-tetrahydrocannabinol in treating patients with cancer-related anorexia-cachexia syndrome: a multicenter, phase III, randomized, double-blind, placebo-controlled clinical trial from the Cannabis-In-Cachexia- Study-Group. J Clin Oncol. 2006 ; 24 (21). 3394-1400.
19. Furler MD, Einarson TR, Millson M., Walmsley S., Bendayan R. Medicinal and recreational marijuana use by patients infected with HIV. AIDS Patient Care STDS. 2004 ; 18 (4). 215-228. (Pubitemid 38558998)
20. Prentiss D., Power R., Balmas G., Tzuang G., Israelski DM Patterns of marijuana use among patients with HIV/AIDS followed in a public health care setting. J Acquir Immune Defic Syndr. 2004 ; 35 (1). 38-45. (Pubitemid 38044780)
21. Woolridge E., Barton S., Samuel J., Osorio J., Dougherty A., Holdcroft A. Cannabis use in HIV for pain and other medical symptoms. J Pain Symptom Manage. 2005 ; 29 (4). 358-367. (Pubitemid 40602516)
22. Fairfield KM, Eisenberg DM, Davis RB, Libman H., Phillips RS Patterns of use, expenditures, and perceived efficacy of complementary and alternative therapies in HIV-infected patients. Arch Intern Med. 1998 ; 158 (20). 2257-2264. (Pubitemid 28512500)
23. Power R., Gore-Felton C., Vosvick M., Israelski DM, Spiegel D. HIV: effectiveness of complementary and alternative medicine. Primary Care. 2002 ; 29 (2). 361-378. (Pubitemid 34760379)
24. Haney M. Effects of smoked marijuana in healthy and HIV + marijuana smokers. J Clin Pharmacol. 2002 ; 42 (11 suppl). 34S - 40S. (Pubitemid 35205044)
25. Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents. Department of Health and Human Services ; Washington D.C. November 3, 2008: 1-139.
26. de Jong BC, Prentiss D., McFarland W., Machekano R., Israelski DM Marijuana use and its association with adherence to antiretroviral therapy among HIV-infected persons with moderate to severe nausea. J Acquir Immune Defic Syndr. 2005 ; 38 (1). 43-46. (Pubitemid 40094117)
27. Ellis RJ, Toperoff W., Vaida F., et al. Smoked medicinal cannabis for neuropathic pain in HIV: a randomized, crossover clinical trial. Neuropsychopharmacology. 2009 ; 34 (3). 672-680.
28. Abrams DI, Jay CA, Shade SB, et al. Cannabis in painful HIVassociated sensory neuropathy: a randomized placebo-controlled trial. Neurology. 2007 ; 68 (7). 515-521.
29. Nocon A., Wittchen HU, Pfister H., et al. Dependence symptoms in young cannabis users? A prospective epidemiological study. J Psychiatr Res. 2006 ; 40 (5). 394-403. (Pubitemid 43816585)
30. Budney AJ, Hughes JR, Moore BA, Vandrey R. Review of the validity and significance of cannabis withdrawal syndrome. Am J Psychiatry. 2004 ; 161 (11). 1967-1977. (Pubitemid 39441395)
31. Wu TC, Tashkin DP, Djahed B., Rose JE Pulmonary hazards of smoking marijuana as compared with tobacco. N Engl J Med. 1988 ; 318 (6). 347.
32. Kolodny RC, Masters WH, Kolodner RM, Toro G. Depression of plasma testosterone levels after chronic intensive marihuana use. N Engl J Med. 1974 ; 290 (16). 872-874.
33. Hembree WC, Nahas GG, Zeidenberg P., et al. Changes in human spermatozoa associated with high-dose marijuana smoking. In: Nahas GG, ed. Marijuana and Medicine. Totowa, NJ: Humana Press; 2001.
34. Solowij N., Stephens RS, Roffman RA, et al. for the Marijuana Treatment Project Research Group. Cognitive functioning of long-term heavy cannabis users seeking treatment. JAMA. 2002 ; 287 (9). 1123-1131. (Pubitemid 34252081)
35. Andreasson S., Allebeck P., Engstrom A., Rydberg U. Cannabis and schizophrenia. A longitudinal study of Swedish conscripts. Lancet. 1987 ; 2 (8574). 1483-1486.
36. Zammit S., Allebeck P., Andreasson S., et al. Self reported cannabis use as a risk factor for schizophrenia in Swedish conscripts of 1969: historical cohort study. BMJ. 2002 ; 325 (7374). 1199.
37. Patton GC, Coffey C., Carlin JB, Degenhardt L., Lynskey M., Hall W. Cannabis use and mental health in young people: cohort study. BMJ. 2002 ; 325 (7374). 1195-1198. (Pubitemid 35398781)
38. Mittleman MA, Lewis RA, Maclure M., Sherwood JB, Muller JE Triggering myocardial infarction by marijuana. Circulation. 2001 ; 103 (23). 2805-2809.
39. Klein TW, Friedman H., Specter S. Marijuana, immunity and infection. J Neuroimmunol. 1998 ; 83 (1-2). 102-115. (Pubitemid 28280956)
40. Lane SD, Cherek DR, Tcheremissine OV, Lieving LM, Pietras CJ Acute marijuana effects on human risk taking. Neuropsychopharmacology. 2005 ; 30 (4). 800-809. (Pubitemid 40397087)
41. Abrams DI, Hilton JF, Leiser RJ, et al. Short-term effects of cannabinoids in patients with HIV-1 infection: a randomized, placebo-controlled clinical trial. Ann Intern Med. 2003 ; 139 (4). 258-266.